These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18648499)

  • 1. A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.
    Martinez GQ; Maduke M
    PLoS One; 2008 Jul; 3(7):e2746. PubMed ID: 18648499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome.
    Cheng CJ; Lo YF; Chen JC; Huang CL; Lin SH
    J Physiol; 2017 Aug; 595(16):5573-5586. PubMed ID: 28555925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.
    Gradogna A; Babini E; Picollo A; Pusch M
    J Gen Physiol; 2010 Sep; 136(3):311-23. PubMed ID: 20805576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and structural analysis of ClC-K chloride channels involved in renal disease.
    Waldegger S; Jentsch TJ
    J Biol Chem; 2000 Aug; 275(32):24527-33. PubMed ID: 10831588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and inhibition of kidney CLC-K chloride channels by fenamates.
    Liantonio A; Picollo A; Babini E; Carbonara G; Fracchiolla G; Loiodice F; Tortorella V; Pusch M; Camerino DC
    Mol Pharmacol; 2006 Jan; 69(1):165-73. PubMed ID: 16244177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome.
    Thakker RV
    Exp Nephrol; 2000; 8(6):351-60. PubMed ID: 11014932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.
    Estévez R; Boettger T; Stein V; Birkenhäger R; Otto E; Hildebrandt F; Jentsch TJ
    Nature; 2001 Nov; 414(6863):558-61. PubMed ID: 11734858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting a regulatory calcium-binding site of CLC-K kidney chloride channels.
    Gradogna A; Fenollar-Ferrer C; Forrest LR; Pusch M
    J Gen Physiol; 2012 Dec; 140(6):681-96. PubMed ID: 23148261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.
    Zifarelli G; Liantonio A; Gradogna A; Picollo A; Gramegna G; De Bellis M; Murgia AR; Babini E; Camerino DC; Pusch M
    Br J Pharmacol; 2010 Aug; 160(7):1652-61. PubMed ID: 20649569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.
    Picollo A; Liantonio A; Didonna MP; Elia L; Camerino DC; Pusch M
    EMBO Rep; 2004 Jun; 5(6):584-9. PubMed ID: 15167890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CLCNKB mutations at dimer-interface, calcium-binding site, and pore reveals a variety of functional alterations in ClC-Kb channel leading to Bartter syndrome.
    Bignon Y; Sakhi I; Bitam S; Bakouh N; Keck M; Frachon N; Paulais M; Planelles G; Teulon J; Andrini O
    Hum Mutat; 2020 Apr; 41(4):774-785. PubMed ID: 31803959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the serum- and glucocorticoid-dependent kinases.
    Embark HM; Böhmer C; Palmada M; Rajamanickam J; Wyatt AW; Wallisch S; Capasso G; Waldegger P; Seyberth HW; Waldegger S; Lang F
    Kidney Int; 2004 Nov; 66(5):1918-25. PubMed ID: 15496163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of CLC-0 chloride channels from separated transmembrane and cytoplasmic domains.
    Maduke M; Williams C; Miller C
    Biochemistry; 1998 Feb; 37(5):1315-21. PubMed ID: 9477958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals a conserved interaction interface.
    Markovic S; Dutzler R
    Structure; 2007 Jun; 15(6):715-25. PubMed ID: 17562318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights into the Mechanism of NO
    Lagostena L; Zifarelli G; Picollo A
    J Am Soc Nephrol; 2019 Feb; 30(2):293-302. PubMed ID: 30635372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional analysis of novel mutations of the CLCNKB gene in Chinese patients with classic Bartter syndrome.
    Yu Y; Xu C; Pan X; Ren H; Wang W; Meng X; Huang F; Chen N
    Clin Genet; 2010 Feb; 77(2):155-62. PubMed ID: 19807735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.
    Thakker RV
    Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):385-8. PubMed ID: 9690036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CLC-KB gene promoter drives the EGFP expression in the specific distal nephron segments and inner ear.
    Kobayashi K; Uchida S; Okamura HO; Marumo F; Sasaki S
    J Am Soc Nephrol; 2002 Aug; 13(8):1992-8. PubMed ID: 12138129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt-losing nephropathy in mice with a null mutation of the Clcnk2 gene.
    Grill A; Schießl IM; Gess B; Fremter K; Hammer A; Castrop H
    Acta Physiol (Oxf); 2016 Nov; 218(3):198-211. PubMed ID: 27421685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role and function of voltage-gated chloride channels of the CIC family and their defects leading to genetic diseases].
    Dołowy K; Bednarczyk P; Hordejuk R; Dworakowska B; Nurowska E; Jarzabek W
    Postepy Hig Med Dosw; 2002; 56(3):307-13. PubMed ID: 12194243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.